TSS
AMRX icon

Two Sigma Securities’s Amneal Pharmaceuticals AMRX Stock Holding History

Two Sigma Securities’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,582
Closed -$88K – 1654
2024
Q3 		$88K Buy
+10,582
New +$82.7K ﹤0.01% 2301
2023
Q1 		– Sell
-29,803
Closed -$59.3K – 2617
2022
Q4 		$59.3K Buy
29,803
+5,727
+24% +$12.8K ﹤0.01% 2137
2022
Q3 		$49K Buy
+24,076
New +$67.5K ﹤0.01% 2183
2022
Q2 		– Sell
-14,392
Closed -$60K – 2185
2022
Q1 		$60K Buy
+14,392
New +$63.7K ﹤0.01% 1855

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return